| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.64B | 6.54B | 6.78B | 6.16B | 5.41B | 4.73B |
| Gross Profit | 1.98B | 1.88B | 2.02B | 1.42B | 1.35B | 1.25B |
| EBITDA | 2.21B | 3.34B | 2.17B | 1.77B | 1.45B | 1.40B |
| Net Income | 1.15B | 2.00B | 1.17B | 867.00M | 702.50M | 721.00M |
Balance Sheet | ||||||
| Total Assets | 18.65B | 18.17B | 15.13B | 14.99B | 14.39B | 10.58B |
| Cash, Cash Equivalents and Short-Term Investments | 57.00M | 670.00M | 1.27B | 358.00M | 258.40M | 207.30M |
| Total Debt | 5.90B | 5.80B | 4.73B | 5.43B | 5.53B | 3.08B |
| Total Liabilities | 8.91B | 8.71B | 7.09B | 7.82B | 7.86B | 4.69B |
| Stockholders Equity | 9.73B | 9.45B | 8.03B | 7.17B | 6.54B | 5.89B |
Cash Flow | ||||||
| Free Cash Flow | 1.01B | 604.00M | 878.00M | 509.00M | 714.60M | 690.40M |
| Operating Cash Flow | 1.84B | 1.46B | 1.53B | 991.00M | 1.14B | 1.05B |
| Investing Cash Flow | -2.59B | -2.44B | 459.00M | -484.00M | -3.47B | -409.70M |
| Financing Cash Flow | 769.00M | 373.00M | -1.06B | -407.00M | 2.29B | -357.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $16.29B | 11.69 | 7.10% | 0.80% | -6.34% | 210.97% | |
77 Outperform | $7.12B | 16.39 | 30.10% | 0.45% | 1.50% | -4.44% | |
77 Outperform | $38.96B | 35.05 | 13.56% | 0.66% | 6.54% | 32.48% | |
73 Outperform | $37.65B | 32.89 | 11.63% | 0.52% | 1.99% | -41.08% | |
70 Outperform | $2.39B | 13.35 | 26.21% | 1.17% | 15.70% | 19.92% | |
67 Neutral | $3.75B | 25.42 | 9.71% | ― | 5.52% | -25.56% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
On November 4, 2025, Martin Marietta reported record financial results for the third quarter of 2025, with significant increases in revenues, gross profit, and earnings from operations compared to the previous year. The company achieved all-time quarterly records in its aggregates business and raised its full-year guidance for Consolidated Adjusted EBITDA. The acquisition of Premier Magnesia and a strategic asset exchange with Quikrete Holdings are expected to enhance Martin Marietta’s portfolio and operational capabilities.
On September 16, 2025, Martin Marietta Materials, Inc. and its subsidiary entered into the Seventeenth Amendment to extend the maturity date of their $400 million trade receivables securitization facility to September 16, 2026. This amendment allows for potential increase of the facility to $600 million, impacting the company’s financial operations by providing more flexibility in managing its trade receivables and potentially enhancing its liquidity position.